Relay Therapeutics Inc (RLAY) institutional holders · rev $15.4M
Relay Therapeutics Inc institutional holders from SEC Form 13F, top 4 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| FMR LLC | 20,110,113 | $376.3M | 2026-06-30 |
| STATE STREET CORP | 10,125,381 | $189.5M | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 2,541,861 | $25.3M | 2026-03-31Prior quarter |
| CITADEL ADVISORS LLC | 176,265 | $1.8M | 2026-03-31Prior quarter |
RLAY institutional holders FAQ
How many RLAY 13F holders are listed on this page?
This page lists 2 cached Relay Therapeutics Inc (RLAY) 13F holders. Holders: https://lician.com/institutional/rlay
Who is the largest RLAY 13F holder by reported value?
The largest cached 13F holder by reported value on this page is FMR LLC. Filer: https://lician.com/institutional/rlay/315066. Holders: https://lician.com/institutional/rlay
What value and shares did the largest RLAY 13F holder report?
FMR LLC, the largest cached 13F holder by reported value on this page, reported 20,110,113 shares and a value of $376.3M.
What is the latest RLAY 13F report date on this page?
The latest cached 13F report date on this Relay Therapeutics Inc (RLAY) holders table is Jun 30, 2026.
Which RLAY 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Relay Therapeutics Inc (RLAY) page are FMR LLC and STATE STREET CORP. Holders: https://lician.com/institutional/rlay
Where are RLAY institutional holders listed?
Cached 13F holders for Relay Therapeutics Inc (RLAY) are listed at https://lician.com/institutional/rlay. Filer directory: https://lician.com/holders
What is RLAY's latest revenue?
Latest cached Relay Therapeutics Inc (RLAY) revenue for Dec 31, 2025 was $15.4M. Statements: https://lician.com/financials/rlay
Not investment advice. Figures as filed or reported, not a live feed.